Jurgi Camblong Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 20 hours ago
Jurgi Camblong has an estimated net worth of at least $19.0 million*, as of yesterday. They own 3.6 million shares of SOPH stock. They have sold 96,055 shares of SOPH stock since 2021, for an estimated $472,229.
Jurgi Camblong $SOPH SEC Form 4 Insider Trading
Jurgi Camblong has filed a total of 11 insider trades in $SOPH since 2021. Their most recent trade was a sale of 4,486 shares, made on Apr 20, 2026. Their largest trade was a sale of 43,129 shares, made on Apr 14, 2026. We estimate that they now own 3.6 million shares of $SOPH, worth an estimated $18.6 million.
Insider Trading at $SOPH
There have been a total of 65 insider trades reported at $SOPH since 2021, with 0 shares purchased and 198,862 shares sold. The most active insider traders in $SOPH stock have been Jurgi Camblong, Philippe Menu, and Zhenyu Xu. The most recent trade was a sale of 5,000 shares reported by Philippe Menu (Chief Medical Officer), made on Apr 27, 2026.
History of Insider Stock Trades by Jurgi Camblong
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
SOPH
|
Sale | 4,486 | Apr 20, 2026 | April 21, 2026, 4:04 p.m. |
|
SOPH
|
Sale | 43,129 | Apr 14, 2026 | April 16, 2026, 4:03 p.m. |
|
SOPH
|
Sale | 17,473 | Apr 15, 2026 | April 16, 2026, 4:03 p.m. |
|
SOPH
|
Sale | 4,399 | Apr 13, 2026 | April 14, 2026, 4:02 p.m. |
|
SOPH
|
Sale | 3,732 | Apr 10, 2026 | April 14, 2026, 4:02 p.m. |
|
SOPH
|
Sale | 8,500 | Apr 10, 2026 | April 14, 2026, 4:02 p.m. |
|
SOPH
|
Sale | 2,800 | Apr 08, 2026 | April 10, 2026, 4:02 p.m. |
|
SOPH
|
Sale | 1,950 | Apr 09, 2026 | April 10, 2026, 4:02 p.m. |
|
SOPH
|
Sale | 2,600 | Apr 06, 2026 | April 8, 2026, 4:04 p.m. |
|
SOPH
|
Sale | 2,500 | Apr 07, 2026 | April 8, 2026, 4:04 p.m. |
|
SOPH
|
Sale | 4,486 | Mar 19, 2026 | March 20, 2026, 4:01 p.m. |
$SOPH Executives and Stock Owners with Insider Trades
-
Jurgi Camblong, Chief Executive Officer
-
Philippe Menu, Chief Medical Officer
-
Zhenyu Xu, Chief Scientific Officer
-
Ross Muken, President
-
Well Daan Van, Chief Legal Officer
-
Kevin Puylaert, Chief Sales Officer
-
Manuela Valente, Chief People Officer
-
George Cardoza, Chief Financial Officer
-
Abhimanyu Verma, Chief Technology Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.